StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 6/30
$6.47+0.00 (0.00%)

Close on Nov 13, 2026Market cap $464.94MP/E –Yield 850.08%

Earnings

Sinovac Biotech's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Sinovac Biotech's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2025ended Dec 31, 2025Jan 5, 2026during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Sinovac Biotech has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Sinovac Biotech puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Sinovac Biotech filed with the SEC as exhibits to Form 8-K or 6-K

  1. SINOVAC Reports Unaudited First Half of 2026 Financial Results
    6-K
  2. SINOVAC Announces Extension of Deadline to Submit Payment Instructions
    6-K
  3. SINOVAC Regained Compliance With the Nasdaq Global Market’s
    6-K
  4. Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025
    6-K
  5. SINOVAC Receives Nasdaq Notification Regarding
    6-K
  6. SINOVAC Announces Extension of Deadline to Submit Payment Instructions
    6-K
  7. PRESS RELEASE - SINOVAC REPORTS UNAUDITED FIRST HALF OF 2025 FINANCIAL RESULTS
    6-K
  8. PRESS RELEASE - SINOVAC ANNOUNCES APPOINTMENT OF INDEPENDENT AUDITOR
    6-K
  9. SINOVAC Announces Receipt of Nasdaq Notice of
    6-K
  10. SINOVAC BIOTECH LIMITED PRESS RELEASE
    6-K
  11. PRESS RELEASE - SINOVAC RECEIVES NASDAQ NOTIFICATION REGARDING LATE FILING OF 2025 HALF-YEAR REPORT
    6-K
  12. PRESS RELEASE - SINOVAC PROVIDES UPDATE ON ANTIGUA HIGH COURT ORDER AND AUDITOR ENGAGEMENT
    6-K
  13. PRESS RELEASE -SINOVAC ANNOUNCES NASDAQ HEARINGS PANEL GRANTS CONTINUED LISTING
    6-K
  14. Elected Directors of Sinovac Hold the First Board Meeting
    6-K
  15. SINOVAC Board of Directors Strongly Denounces
    6-K

See a number that looks wrong?